Influenza Hemagglutinin mRNA vaccine

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameInfluenza Hemagglutinin mRNA vaccine

Drug Alias NameMonovalent mRNA Vaccine Encoding Influenza Hemagglutinin

ClassificationVaccines > Vaccine type > Univalent vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesSanofi Pasteur

China Registration ClassN/A

Develop Information

Active CompaniesSanofi Pasteur

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A